Tharimmune Inc.
Biotechnology
Healthcare
THAR
1.55 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
1.59
52 week high
3.43
high
1.75
52 week low
1.32
previous Close
1.54
P/E ratio
-1
market cap
3.98 M
div yield
0
net incoming
-3.80 M
-63.26 %
net profit margin
-379585200.00 %
0.00 %
operating incoming
-3.87 M
-62.87 %
net change in cash
-3.12 M
-487.36 %
cash on hand
4.77 M
-39.53 %
top